Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
37,458,543
-
Share change
-
+2,123,189
-
Total reported value
-
$366,342,962
-
Price per share
-
$9.78
-
Number of holders
-
92
-
Value change
-
+$19,901,245
-
Number of buys
-
52
-
Number of sells
-
29
Institutional Holders of MAGENTA THERAPEUTICS INC - COM (MGTA) as of Q2 2021
As of 30 Jun 2021,
MAGENTA THERAPEUTICS INC - COM (MGTA) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,458,543 shares.
The largest 10 holders included
TRV GP IV, LLC, GILDER GAGNON HOWE & CO LLC, Casdin Capital, LLC, Alphabet Inc., Aquilo Capital Management, LLC, BlackRock Inc., ORBIMED ADVISORS LLC, VANGUARD GROUP INC, GREAT POINT PARTNERS LLC, and FMR LLC.
This page lists
92
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.